Abstract
BackgroundRheumatoid arthritis (RA) and ankylosing spondylitis (AS) are both characterised by alterations within T-cell subsets. Studies on the impact of biologic therapies, especially of IL6-receptor-antagonists (IL6ra) on this phenotype are...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have